3.44
Relmada Therapeutics Inc (RLMD) 財務データ
損益計算書
四半期ごと
*すべての数値は百万単位です
| 期間終了日 | 2026-06-30 | 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 |
| 期間の長さ | 3 か月 | 3 か月 | 3 か月 | 3 か月 | 3 か月 |
| Operating Expenses |
22.87%
15.01
|
19.46 | 20.33 | 10.33 | 10.22 |
| Operating Income/Loss |
22.87%
-15.01
|
-19.46 | -20.33 | -10.33 | -10.22 |
| Nonoperating Income/Loss |
411.68%
2.0968
|
0.4098 | 0.4654 | 0.2359 | 0.3549 |
| Net Income/Loss |
32.22%
-12.91
|
-19.05 | -19.87 | -10.09 | -9.8664 |
| Basic Average Shares |
29.77%
112.38
|
86.60 | - | 33.19 | 33.19 |
| Diluted Average Shares |
29.77%
112.38
|
86.60 | - | 33.19 | 33.19 |
| Basic Earnings Per Share |
50.00%
-0.11
|
-0.22 | - | -0.30 | -0.30 |
| Diluted Earnings Per Share |
50.00%
-0.11
|
-0.22 | - | -0.30 | -0.30 |
大文字化:
|
ボリューム (24 時間):